Colossal Biosciences, a startup focused on de-extinction, is reportedly in negotiations to secure new funding that could increase its valuation to between $20 billion and $30 billion. This potential valuation represents a doubling or tripling of its previous worth.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Colossal Biosciences in discussions to raise capital at $20B–$30B valuation
Colossal Biosciences is reportedly negotiating to raise new capital, which could elevate its valuation to between $20 billion and $30 billion. This would mark a significant increase from its prior valuation.
Companies
Colossal Biosciences
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Neutral Headline
Colossal Biosciences in discussions to raise capital at $20B–$30B valuation